XNCR - Xencor Q3 revenues $29M November, 06 2018 07:06 AM Xencor Inc. Xencor (NASDAQ:XNCR) Q3 results (): Revenues: 29.0 (from Novartis collaboration and $9M in milestone payments from Alexion). More news on: Xencor, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...